FDA Rethinks Drug Trials: Bayesian Stats Offer Hope for Rare Diseases

FDA Embraces New Statistical Approach to Accelerate Drug Approval For decades, the gold standard for drug approval in the United States has been the rigorous, independent clinical trial. Each new drug seeking FDA approval was essentially treated as if it…







